# Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

> **NCT07022535** · PHASE2 · RECRUITING · sponsor: **The University of Hong Kong** · enrollment: 18 (estimated)

## Conditions studied

- Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** KELIM
- **DRUG:** Carboplatin plus Paclitaxel
- **PROCEDURE:** Interval debulking surgery

## Key facts

- **NCT ID:** NCT07022535
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-28
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07022535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07022535, "Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07022535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*